Protocol summary
Concise study objective, design, population, endpoints, and duration so reviewers assess scientific validity and feasibility quickly.
A complete Research Study Document reduces regulatory risk, preserves participant rights, and creates an evidentiary trail for audits and inspections. Properly structured documents help satisfy ESIGN (15 U.S.C. ch. 96) and state UETA requirements for electronic records and signatures, support HIPAA controls when protected health information is involved, and clarify responsibilities for investigators and sponsors.
Organizations and individuals who create, review, or sign Research Study Documents vary by role and responsibility but share accountability for accuracy and compliance.
Use this role map to assign tasks, confirm signing authority, and route documents through appropriate review and retention workflows.
| Field | Configuration |
|---|---|
| Authentication | Email link or SMS one-time code |
| Signature Type | Drawn or typed with timestamped audit trail |
| Conditional Fields | Show site-specific consent sections as needed |
| Notifications | Auto-CC sponsor and IRB liaison upon completion |
Choose a platform that supports required authentication, file formats, and audit logging to meet institutional controls and investigator needs.
Concise study objective, design, population, endpoints, and duration so reviewers assess scientific validity and feasibility quickly.
Plain-language explanation of procedures, risks, benefits, and withdrawal rights tailored to the participant population and literacy level.
Describe data collection, storage, de-identification, and any HIPAA-required protections; specify whether a BAA applies for PHI handling.
Define event reporting timelines, responsible parties, and how events will be documented and reported to IRB and sponsor.
Detailed visit schedules, assessments, and sample handling instructions to ensure correct and repeatable operations across sites.
List PI, study coordinator, IRB liaison, and sponsor contacts for questions, reporting, and escalation.
Allow 4–8 weeks for full-board or expedited review
Document the MM/DD/YYYY date when consent version becomes active
Report serious events per sponsor and IRB timelines
Submit changes before implementing procedures at sites
Follow retention schedules tied to study type and sponsor
Finalize protocol and consent before external submission.
Address queries and secure approval prior to enrollment.
Capture signed consents and verify identity/authentication.
Collect final reports and securely archive records.
Optica standardized its consent and protocol templates to reduce reviewer confusion and accelerate site onboarding.
The center implemented secure electronic consent for patients with clinic-supplied tablets.
| signNow | DocuSign | Adobe Sign | PandaDoc | HelloSign | |
|---|---|---|---|---|---|
| Starting Price | $8/user/mo | $15/user/mo | $14/user/mo | $19/user/mo | $15/user/mo |
| Free Trial | 7-day free trial | Varies | Varies | Varies | Varies |
| Bulk Send | Yes | Yes | Yes | Yes | No |
| Audit Trail | Yes | Yes | Yes | Yes | Yes |
| HIPAA Compliant | Yes | Yes | Yes | No | No |